Modeling the Effect of Subcutaneous Lixisenatide on Glucoregulatory Endocrine Secretions and Gastric Emptying in Type 2 Diabetes to Simulate the Effect of iGlarLixi Administration Timing on Blood Sugar Profiles

BACKGROUND: As type 2 diabetes (T2D) progresses, intensification to combination therapies, such as iGlarLixi (a fixed-ratio GLP-1 RA and basal insulin combination), may be required. Here a simulation study was used to assess the effect of iGlarLixi administration timing (am vs pm) on blood sugar pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Gautier, Thibault, Silwal, Rupesh, Saremi, Aramesh, Boss, Anders, Breton, Marc D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847729/
https://www.ncbi.nlm.nih.gov/pubmed/34013770
http://dx.doi.org/10.1177/19322968211015671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847729/
https://www.ncbi.nlm.nih.gov/pubmed/34013770
http://dx.doi.org/10.1177/19322968211015671

Ejemplares similares